CIK 0002104204 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alamar Biosciences, Inc.
Sign in to watch- Ticker
- ALMR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364899036
- Phone
- 510-626-9888
- Business address
- 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,561,405
- in 7 filings
Net −$44,561,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | White Timothy Ogden President | Other acquisition · Stock Option (Right to Buy) | +16,333 | 16,333 | ||
| 2026-04-20 | Chambers Rebecca Director | Other disposition · Stock Option (Right to Buy) | −140,612 | 0 | ||
| 2026-04-20 | Chambers Rebecca Director | Other acquisition · Stock Option (Right to Buy) | +140,612 | 140,612 | ||
| 2026-04-20 | McAnear Justin J. Chief Financial Officer | Grant or award | +37,220 | 37,220 | ||
| 2026-04-20 | McAnear Justin J. Chief Financial Officer | Other disposition · Stock Option (Right to Buy) | −570,719 | 0 | ||
| 2026-04-20 | McAnear Justin J. Chief Financial Officer | Other acquisition · Stock Option (Right to Buy) | +570,719 | 570,719 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion | +4,588,364 | 4,588,364 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion | +922,152 | 5,510,516 | ||
| 2026-04-20 | Naclerio Nicholas Director | Other disposition | −5,510,516 | 0 | ||
| 2026-04-20 | Naclerio Nicholas Director | Other acquisition | +5,510,516 | 5,510,516 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion | +346,020 | 5,856,536 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion | +271,782 | 271,782 | ||
| 2026-04-20 | Naclerio Nicholas Director | Purchase | +235,294 | $17.00 | $4.0M | 507,076 |
| 2026-04-20 | Naclerio Nicholas Director | Grant or award | +5,686 | 5,686 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion · Series A-3 Preferred Stock | −3,194,377 | 0 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion · Series A-4 Preferred Stock | −2,862,507 | 0 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion · Series B Preferred Stock | −2,094,266 | 0 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion · Series C Preferred Stock | −5,037,783 | 0 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2026-04-20 | Naclerio Nicholas Director | Conversion · Convertible Promissory Note | −0 | 0 |
Page 11 of 13 · 244 trades